Regen BioPharma Inc (RGBP)

[jerrybrockman]

Here it is:

Publication number: 20210059962
Abstract: Disclosed are means, methods, and compositions of matter for stimulation of T regulatory (Treg) cells by cannabidiol. In one embodiment, administration of cannabidiol is performed in an animal suffering from autoimmunity. In situations of autoimmunity, cannabidiol induces generation of Treg cells while other agents or therapies may be used to expand such cells in vitro and/or in vivo. In some embodiments the administration of cannabidiol is performed together with agents such as low dose interleukin-2 in order to treat inflammatory conditions such as arthritis or other conditions associated with reduction in Treg cells such as pregnancy failure, type 1 diabetes, or graft versus host disease.
Type: Application
Filed: September 2, 2020
Publication date: March 4, 2021
Applicant: Regen Biopharma, Inc.
Inventors: Thomas Ichim, David Koos

https://patents.justia.com/search?q=Regen+Biopharma

Shortly after, David Koos returns to the helm at $RGBP

Follow the money train.

They are going to license this out and generate big revenue with their unique CBD application to treat autoimmune disease.